Oral intake of apigenin at doses of 20 and 50 g/day over eight weeks resulted in a significant decrease in tumor development, HDAC activity, and HDAC1 and HDAC3 protein expression in PC-3 xenografts in athymic nude mice. This evidence concerns the gene HDAC9 and neoplasm.